ATE201687T1 - Galanthamin-derivat, ein verfahren zu seiner herstellung und seine verwendung als medikament - Google Patents
Galanthamin-derivat, ein verfahren zu seiner herstellung und seine verwendung als medikamentInfo
- Publication number
- ATE201687T1 ATE201687T1 AT94115960T AT94115960T ATE201687T1 AT E201687 T1 ATE201687 T1 AT E201687T1 AT 94115960 T AT94115960 T AT 94115960T AT 94115960 T AT94115960 T AT 94115960T AT E201687 T1 ATE201687 T1 AT E201687T1
- Authority
- AT
- Austria
- Prior art keywords
- galanthamin
- medication
- derivative
- production
- alkylaminocarbonyloxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/137,443 US6323196B1 (en) | 1993-10-15 | 1993-10-15 | Galanthamine derivatives as acetylcholinesterase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE201687T1 true ATE201687T1 (de) | 2001-06-15 |
Family
ID=22477457
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94115960T ATE201687T1 (de) | 1993-10-15 | 1994-10-10 | Galanthamin-derivat, ein verfahren zu seiner herstellung und seine verwendung als medikament |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6323196B1 (de) |
| EP (2) | EP0648771B1 (de) |
| JP (1) | JP2718637B2 (de) |
| KR (1) | KR100189043B1 (de) |
| CN (1) | CN1039011C (de) |
| AT (1) | ATE201687T1 (de) |
| AU (1) | AU679560B2 (de) |
| CA (1) | CA2118171C (de) |
| CZ (1) | CZ283561B6 (de) |
| DE (1) | DE69427332T2 (de) |
| DK (1) | DK0648771T3 (de) |
| EG (1) | EG20747A (de) |
| ES (1) | ES2158876T3 (de) |
| FI (1) | FI108724B (de) |
| GR (1) | GR3036068T3 (de) |
| IL (1) | IL111273A (de) |
| NO (1) | NO307463B1 (de) |
| NZ (1) | NZ264681A (de) |
| PL (1) | PL177754B1 (de) |
| PT (1) | PT648771E (de) |
| RO (1) | RO114132B1 (de) |
| RU (1) | RU2113438C1 (de) |
| TW (1) | TW375615B (de) |
| ZA (1) | ZA948060B (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT403803B (de) | 1996-04-19 | 1998-05-25 | Sanochemia Ltd | Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln |
| US7939522B1 (en) | 1998-11-23 | 2011-05-10 | Bonnie M Davis | Dosage formulations for acetylcholinesterase inhibitors |
| AU775914B2 (en) | 1998-12-24 | 2004-08-19 | Janssen Pharmaceutica N.V. | Controlled release galantamine composition |
| US6670356B2 (en) * | 1999-12-10 | 2003-12-30 | Bonnie Davis | Analogs of galanthamine and lycoramine as modulators of nicotinic receptors |
| EP1181294B1 (de) | 2000-03-31 | 2004-03-31 | Sanochemia Pharmazeutika Aktiengesellschaft | Neue derivate und analoga von galanthamin |
| US20030162770A1 (en) * | 2002-02-22 | 2003-08-28 | Davis Bonnie M. | Use of modulators of nicotinic receptors for treatment of cognitive dysfunction |
| US20040142970A1 (en) * | 2002-11-01 | 2004-07-22 | Kathryn Chung | Treatment of hyperkinetic movement disorder with donepezil |
| US20050048543A1 (en) * | 2003-07-11 | 2005-03-03 | Jeroen Aerssens | CHRNA2 genetic markers associated with galantamine response |
| US20050260613A1 (en) * | 2003-10-28 | 2005-11-24 | Genaissance Pharmaceuticals | LRPAP1 genetic markers associated with galantamine |
| US20050143350A1 (en) * | 2003-11-19 | 2005-06-30 | Seed John C. | Combination drug therapy to treat obesity |
| US7250258B2 (en) * | 2003-12-15 | 2007-07-31 | Pgxhealth Llc | CDK5 genetic markers associated with galantamine response |
| EP1763337A2 (de) * | 2003-12-31 | 2007-03-21 | Actavis Group HF | Galanthamin-formulierungen mit sofortiger, kontrollierter und gleichmässig hinhaltender wirkstofffreisetzung |
| CA2552114A1 (en) * | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Solid dosage formulations of galantamine |
| US20080045500A1 (en) * | 2004-07-01 | 2008-02-21 | Eisai R&D Management Co., Ltd. | Nerve Regeneration Stimulator |
| EP1895995A2 (de) * | 2005-05-13 | 2008-03-12 | Alza Corporation | Mehrschichtige transdermale systeme zur galantamine abgabe |
| US20080188510A1 (en) * | 2005-05-23 | 2008-08-07 | Eisai R & D Management Co., Ltd. | Novel methods using zonisamide |
| EP1777222A1 (de) * | 2005-09-22 | 2007-04-25 | Galantos Pharma GmbH | Cholinesterase Inhibitoren mit erhöter Blut Hirn Schranke Permeabilität zur Behandlung von kognitiven Störungen |
| US20090253654A1 (en) | 2005-09-22 | 2009-10-08 | Galantos Pharma Gmbh | Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
| WO2007035941A2 (en) * | 2005-09-23 | 2007-03-29 | Alza Corporation | Transdermal galantamine delivery system |
| KR100786371B1 (ko) * | 2006-12-07 | 2007-12-17 | 한국화학연구원 | 갈란타민의 제조방법 |
| PL2137192T3 (pl) | 2008-04-14 | 2014-07-31 | Neurodyn Life Sciences Inc | Pochodne galantaminy jako proleki do leczenia chorób mózgu u ludzi |
| JP2013500268A (ja) * | 2009-07-23 | 2013-01-07 | シャイア エルエルシー | ガランタミンアミノ酸およびペプチドプロドラッグならびにその使用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL122665B1 (en) | 1978-11-21 | 1982-08-31 | Edinen Zentar Chim | Process for preparing novel dienones of narvedine type and their derivatives |
| US4663318A (en) | 1986-01-15 | 1987-05-05 | Bonnie Davis | Method of treating Alzheimer's disease |
| WO1988008708A1 (en) * | 1987-05-04 | 1988-11-17 | Bonnie Davis | Compounds for the treatment of alzheimer's disease |
| US6150354A (en) * | 1987-01-15 | 2000-11-21 | Bonnie Davis | Compounds for the treatment of Alzheimer's disease |
| NL8800350A (nl) | 1988-02-12 | 1989-09-01 | Stichting Biomedical Research | Synthetische galanthamine-derivaten, werkwijze voor het bereiden daarvan, en farmaceutische samenstellingen. |
| US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
| WO1992020327A1 (en) | 1991-05-14 | 1992-11-26 | Ernir Snorrason | Treatment of fatigue syndrome with cholinesterase inhibitors |
| US5231093A (en) * | 1991-10-01 | 1993-07-27 | Hoechst-Roussel Pharmaceuticals Incorporated | Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs |
| US5153193A (en) | 1991-10-01 | 1992-10-06 | Hoechst-Roussel Pharmaceuticals Incorporated | Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs |
-
1993
- 1993-10-15 US US08/137,443 patent/US6323196B1/en not_active Expired - Lifetime
-
1994
- 1994-10-10 PT PT94115960T patent/PT648771E/pt unknown
- 1994-10-10 ES ES94115960T patent/ES2158876T3/es not_active Expired - Lifetime
- 1994-10-10 EP EP94115960A patent/EP0648771B1/de not_active Expired - Lifetime
- 1994-10-10 DE DE69427332T patent/DE69427332T2/de not_active Expired - Lifetime
- 1994-10-10 AT AT94115960T patent/ATE201687T1/de active
- 1994-10-10 EP EP00107569A patent/EP1020469A3/de not_active Withdrawn
- 1994-10-10 DK DK94115960T patent/DK0648771T3/da active
- 1994-10-12 EG EG63794A patent/EG20747A/xx active
- 1994-10-13 NZ NZ264681A patent/NZ264681A/en not_active IP Right Cessation
- 1994-10-13 FI FI944822A patent/FI108724B/fi not_active IP Right Cessation
- 1994-10-13 IL IL111273A patent/IL111273A/en not_active IP Right Cessation
- 1994-10-13 RU RU94036761A patent/RU2113438C1/ru active
- 1994-10-14 RO RO94-01668A patent/RO114132B1/ro unknown
- 1994-10-14 PL PL94305455A patent/PL177754B1/pl unknown
- 1994-10-14 CA CA002118171A patent/CA2118171C/en not_active Expired - Lifetime
- 1994-10-14 CN CN94117061A patent/CN1039011C/zh not_active Expired - Lifetime
- 1994-10-14 CZ CZ942547A patent/CZ283561B6/cs not_active IP Right Cessation
- 1994-10-14 ZA ZA948060A patent/ZA948060B/xx unknown
- 1994-10-14 TW TW083109528A patent/TW375615B/zh not_active IP Right Cessation
- 1994-10-14 AU AU75812/94A patent/AU679560B2/en not_active Expired
- 1994-10-14 KR KR1019940026304A patent/KR100189043B1/ko active IP Right Grant
- 1994-10-14 NO NO943894A patent/NO307463B1/no not_active IP Right Cessation
- 1994-10-17 JP JP6250776A patent/JP2718637B2/ja not_active Expired - Fee Related
-
2001
- 2001-06-19 GR GR20010400911T patent/GR3036068T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE201687T1 (de) | Galanthamin-derivat, ein verfahren zu seiner herstellung und seine verwendung als medikament | |
| ATE212348T1 (de) | Galanthamin derivate, ein verfahren zu ihrer herstellung und ihre verwendung als medikamente | |
| CA2132199A1 (en) | Depsipeptide derivative, production thereof and use thereof | |
| DE50011034D1 (de) | N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| ATE242241T1 (de) | Imidazopyridinderivate und verfahren zu ihrer herstellung | |
| DE69231874T2 (de) | Verfahren zur herstellung von 4-substituierten azetidinon-derivaten | |
| ATE164582T1 (de) | 1-methylcarbapenemderivate und verfahren zu ihrer herstellung | |
| ATE211474T1 (de) | Galanthamin derivate, verfahren zu ihrer herstellung und ihre verwendung als medikamente | |
| ATE191461T1 (de) | Verfahren zur herstellung von alkoxyimino acetamid-derivaten | |
| EP0555479A4 (de) | ||
| DE59905700D1 (de) | N-phenylacetoacetamide und Verfahren zu ihrer Herstellung | |
| TW350835B (en) | Process for preparing nitroaniline derivatives | |
| ATE402940T1 (de) | Verfahren zur herstellung von 3-cephem- verbindungen | |
| ATE189887T1 (de) | Vitamin-d-derivat und verfahren zu seiner herstellung | |
| DE3884518D1 (de) | Naphthothiazepin-derivate und verfahren zu ihrer herstellung. | |
| ATE67194T1 (de) | Thiadiazolylacetamid-derivate, verfahren zu ihrer herstellung und ihre verwendung. | |
| ATE225350T1 (de) | Verfahren zur herstellung von folsäure | |
| DE69628887D1 (de) | Verfahren zur herstellung von beta-lactamderivaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EEIH | Change in the person of patent owner |